Skip to main content

Presentation at 5th annual Welsh Rare Disease Patient Network Meeting

AWTTC outlined the AWMSG process for appraising medicines used to treat rare conditions. AWTTC presented results from a review of the process for appraising a medicine for a rare disease and highlighted the changes to the policy implemented following the review.

Please click here for more information on the AWMSG appraisal process for a medicine for a rare disease.

Follow AWTTC: